Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (1040)

« Back to Publications

Reply to Siddiqui et al. , Godbout et al. , and to Chang and Mao

Chupp G. et al, (2026), American Journal of Respiratory and Critical Care Medicine

Targeting disease activity to predict and prevent damage in obstructive airway diseases

Pavord ID., (2026), Annals of Allergy, Asthma & Immunology

The PGD2/DP2 axis promotes pro-inflammatory responses but attenuates an antigen-presenting role of human basophils

Luo J. et al, (2026), Communications Biology

After the escalator

Gronnier M. et al, (2026), Annals of Allergy, Asthma & Immunology

Preschool wheeze endotypes and their association with asthma attacks and inhaled corticosteroid response.

Perikleous A. et al, (2026), ERJ open research, 12, 1183 - 2025

Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma+COPD: the NOVELTY study

Muiser S. et al, (2026), Thorax

Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review.

Brusselle G. et al, (2026), Pulmonary therapy, 12, 57 - 78

Acceptability and feasibility of biomarkers of airway eosinophilic inflammation for the management of preschool wheeze: a qualitative study.

Perikleous A. et al, (2026), Archives of disease in childhood, 111, 347 - 355

Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthma.

Pavord ID. et al, (2026), The Journal of allergy and clinical immunology, 157, 363 - 373

Evaluating Asthma Clinical Remission with Inhaled Therapy: Post Hoc Analyses of CAPTAIN.

Oppenheimer J. et al, (2026), Advances in therapy, 43, 729 - 749

Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE).

Chupp G. et al, (2026), American journal of respiratory and critical care medicine

Shaping the Future of Respiratory Care: A Look Into the Next Decade and Strategic Recommendations by European Forum for Research and Education in Allergy and Airways Diseases.

Bertels X. et al, (2026), Chest

Normal FEV1 without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis

Couillard S. et al, (2025), American Journal of Respiratory and Critical Care Medicine, 211, 2396 - 2399

Understanding the relationship between eosinophils and chronic obstructive pulmonary disease. A new dawn?

Tiedeman C. and Pavord I., (2025), Expert review of respiratory medicine, 1 - 9

Biological Therapies in Chronic Obstructive Pulmonary Disease: New Directions in Personalised Respiratory Medicine

Mappin-Kasirer B. and Pavord ID., (2025), BioDrugs, 39, 827 - 839

Load More

1
2
3
4
5
6
7
...
»